About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Houston | 107 Studies

Clinical Trials Multiple SclerosisHouston

Multiple Sclerosis Clinical Trials in Houston

Find 107 clinical trials for multiple sclerosis near Houston, Texas. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 107 trials

CompletedA Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple SclerosisThis was a Phase II, randomized, open-label, rater-blinded, three-arm study comparing two different doses of alemtuzumab (Lemtrada™) and one dose of subcutaneous (SC) interferon…NCT00050778·Scottsdale, Arizona and 48 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedCombination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRxThis is for a randomized clinical trial (RCT) to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either…NCT00211887·Birmingham, Alabama and 70 others

CompletedAn Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MSThe purpose of this study is to determine the difference in preventing a relapse between Betaseron and Avonex.NCT00206648·Tucson, Arizona and 52 others

CompletedSafety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple SclerosisThe objectives of the study are to evaluate the safety, tolerability, and efficacy of 3 doses of AVP-923 capsules in the treatment of central neuropathic pain in participants with…NCT01324232·Cullman, Alabama and 71 others

CompletedAn Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of AlemtuzumabThis open-label, rater-blinded extension study enrolled participants who had relapsing-remitting multiple sclerosis (RRMS) and who participated in one of three prior…NCT00930553·Cullman, Alabama and 175 others

TerminatedOpen Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple SclerosisThe purpose of this study is to further evaluate the safety and efficacy of Tovaxin in the treatment of relapsing forms of multiple sclerosis.NCT00595920·Cullman, Alabama and 26 others

CompletedStudy of Fampridine-ER Tablets in Patients With Multiple SclerosisThe purpose of this study is to investigate the safety and efficacy of a lower dose of dalfampridine extended release tablets compared to the currently approved dose in improving…NCT01328379·Cullman, Alabama and 69 others

CompletedSafety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking ImpairmentThis study assessed the efficacy and safety of ADS-5102 (at daily doses of 137 mg or 274 mg) compared with placebo in MS patients with walking impairment.NCT03436199·Cullman, Alabama and 83 others

UnknownMotor Skill Acquisition Between Individuals With Neurological Disorders and Healthy IndividualsStroke survivors frequently show persistent gait deficits in their chronic stages even after years of intensive rehabilitation.NCT04503187·Houston, Texas

RecruitingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOThis phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum…NCT03816345·Birmingham, Alabama and 51 others

CompletedA Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)To evaluate the effectiveness, safety and Patient-Reported Outcomes (PROs) of cladribine tablets in participants with RMS including relapsing-remitting multiple sclerosis (RRMS)…NCT03933202·Cullman, Alabama and 65 others

UnknownOptic Neuritis Treatment Trial (ONTT)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000146·Little Rock, Arkansas and 14 others

CompletedEfficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple SclerosisTo compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide administered orally once daily in patients with relapsing…NCT02792218·Phoenix, Arizona and 165 others

CompletedA Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple SclerosisThe purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with relapsing Multiple Sclerosis (RMS).NCT03737851·Birmingham, Alabama and 48 others

CompletedA 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple SclerosisThe purpose of this study is to evaluate the change in patient-reported outcomes, physician assessment of a change as well as safety and tolerability in patients with Relapsing…NCT01216072·Birmingham, Alabama and 148 others

CompletedA Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)The goal of this study was to evaluate the safety, tolerability and effectiveness of oral cladribine when taken in combination with Interferon-beta (IFN-beta) therapy for the…NCT00436826·Cullman, Alabama and 38 others

CompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisThe purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting…NCT00030966·Birmingham, Alabama and 87 others

CompletedEfficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple SclerosisTo determine if treatment with BG00012 can decrease the number of MS relapses during a certain time period.NCT00451451·Birmingham, Alabama and 194 others

CompletedBEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New DoseThe BEYOND Follow-Up study will give patients who participated in the preceding BEYOND study the opportunity to continue treatment with the 500µg dose of interferon beta (IFNB) 1b…NCT00459667·Birmingham, Alabama and 183 others

CompletedEnvironmental and Genetic Risk Factors for Pediatric Multiple SclerosisThe purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or…NCT01396343·Birmingham, Alabama and 16 others

PreviousPage 3 of 6Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia